|Application:||miRNA array analysis|
|Number of samples:||119|
|Release date:||May 5 2018|
|Last update date:||May 6 2018|
|Diseases:||Urinary Bladder Neoplasms, Lipoma, Liposarcoma, Tumor Lysis Syndrome|
|Dataset link||Trancriptional profiling of rat bladder after daily administration of Pioglitazone and Rosiglitazone in vivo (miRNA)|
Sprague-Dawley rats were dosed for 3 time periods: 3, 28 or 90 days. The animals (10/sex/group) were dosed orally with vehicle (0.5 % methylcellulose), Pioglitazone (13 and 63 mg/kg/day) or Rosiglitazone (10 mg/kg/day). Bladder urothelium was isolated from 5 animals/sex/group and further processed for transcriptional profiling.